PUBLISHER: The Business Research Company | PRODUCT CODE: 2127587
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127587
Ribonucleic acid (RNA) extraction kits are specialized laboratory solutions used for the isolation and purification of RNA from biological samples. These kits include chemical reagents and purification components that facilitate the separation of RNA from cellular materials and unwanted contaminants. Ribonucleic acid (RNA) extraction kits are designed to enhance the quality, purity, and stability of extracted RNA, enabling reliable molecular analysis and supporting efficient processing in research and diagnostic applications.
The primary product types of ribonucleic acid (RNA) extraction kits include manual kits and automated kits. Manual kits refer to extraction systems that require user-operated processing steps to isolate RNA from biological samples. These kits utilize technologies such as silica-based extraction, phenol-chloroform extraction, and column-based extraction and are designed for sample types including blood, tissue, cells, and other sample types. They are used in applications such as reverse transcription polymerase chain reaction, next-generation sequencing, gene expression analysis, transcriptomics research, molecular diagnostics, and others, supporting end users including hospitals and diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies, and others.
Tariffs are influencing the ribonucleic acid (RNA) extraction kits market by increasing the cost of raw materials, laboratory consumables, and imported reagents used in kit manufacturing, thereby raising overall production expenses for manufacturers. This has particularly affected segments such as column-based and automated extraction kits, which rely heavily on precision components and globally sourced materials. Regions dependent on imports, especially Asia-Pacific and parts of Europe, are experiencing supply chain delays and higher end-user pricing across hospitals, academic institutes, and biotechnology companies. In response, manufacturers are localizing production, diversifying suppliers, and optimizing kit designs to maintain affordability and ensure continuity in molecular diagnostic workflows.
The ribonucleic acid (rna) extraction kits market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) extraction kits market statistics, including ribonucleic acid (rna) extraction kits industry global market size, regional shares, competitors with a ribonucleic acid (rna) extraction kits market share, detailed ribonucleic acid (rna) extraction kits market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) extraction kits industry. This ribonucleic acid (rna) extraction kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid (RNA) extraction kits market size has grown rapidly in recent years. It will grow from $2.27 billion in 2025 to $2.51 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increasing adoption of molecular diagnostics in clinical laboratories, expansion of genomic and transcriptomic research studies, rising prevalence of infectious and genetic diseases requiring rna analysis, growth in pharmaceutical r&d activities, standardization of laboratory workflows for nucleic acid extraction.
The ribonucleic acid (RNA) extraction kits market size is expected to see rapid growth in the next few years. It will grow to $3.68 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized therapeutics, expansion of next generation sequencing based applications, increasing automation in sample preparation workflows, growth in decentralized and point of care diagnostic testing, rising investments in biotechnology and life science research infrastructure. Major trends in the forecast period include automated high-throughput rna isolation systems for large scale molecular workflows, ultra pure contamination free rna extraction enhancing downstream sequencing accuracy, microfluidic based sample preparation platforms enabling rapid rna purification, portable and point of care molecular extraction kits for decentralized diagnostics, cost optimized spin column and magnetic bead based extraction formats improving laboratory efficiency.
The increasing genomic research is expected to propel the growth of the ribonucleic acid (RNA) extraction kits market going forward. Genomic research encompasses scientific investigations involving gene sequencing, transcriptomics, molecular biology, and genetic analysis for applications across healthcare and life sciences. The growth in genomic research is driven by the expanding adoption of next-generation sequencing (NGS) technologies, which provide faster, more precise, and cost-effective genetic material analysis. Ribonucleic acid (RNA) extraction kits facilitate genomic research by enabling the efficient isolation and purification of high-quality RNA from biological samples for downstream genetic analysis, supporting accurate gene expression profiling and molecular characterization. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, by the end of the first quarter (Q1) 2023, there were 247 gene therapies in Phase II clinical development, and this figure increased by 5% to 260 therapies by the end of the second quarter (Q2) 2023. Therefore, the increasing genomic research is driving the growth of the ribonucleic acid (RNA) extraction kits market.
The rising prevalence of infectious diseases is expected to propel the growth of the ribonucleic acid (RNA) extraction kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, that spread through direct or indirect transmission. The increase in infectious diseases is mainly attributed to rapid urbanization, as densely populated urban areas encourage closer human contact and accelerate disease transmission. RNA extraction kits support infectious disease diagnostics by enabling the efficient isolation and purification of viral RNA from clinical samples for accurate molecular testing. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the rising prevalence of infectious diseases is driving the growth of the ribonucleic acid (RNA) extraction kits market.
Major companies operating in the ribonucleic acid (RNA) extraction kit market are emphasizing the development of automated extraction systems, including magnetic bead-based viral nucleic acid extraction kits, to improve nucleic acid purification efficiency, enhance viral detection sensitivity, and optimize high-throughput laboratory workflows. A magnetic bead-based viral nucleic acid extraction kit is a laboratory solution designed to isolate and purify viral deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from biological samples using magnetic bead separation technology. For instance, in April 2024, New England Biolabs, a US-based life sciences company, introduced the Monarch Mag Viral DNA or RNA Extraction Kit to enable rapid, high-yield, and automated viral nucleic acid purification for sensitive molecular diagnostics and infectious disease detection. The kit employs magnetic bead-based extraction chemistry to deliver highly sensitive viral RNA recovery and automated, hands-free processing across a range of liquid handling platforms. It also supports scalable purification of saliva, respiratory swab, and wastewater samples for sequencing and molecular diagnostic applications.
Major companies operating in the ribonucleic acid (RNA) extraction kits market report are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva Life Sciences, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., Tiangen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Omega Bio-tek Inc., Illumina Inc., Revvity Inc., Covaris LLC, GenScript Biotech Corporation
North America was the dominating region in the ribonucleic acid (RNA) extraction kits market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) extraction kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) extraction kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid (RNA) extraction kits market consists of sales of spin column purification kits, magnetic bead-based extraction kits, viral RNA isolation kits, and total RNA purification kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid (RNA) Extraction Kits Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ribonucleic acid (rna) extraction kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ribonucleic acid (rna) extraction kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) extraction kits market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.